Nuvo Research acquires ZARS Pharma - MarketLine Financial Deals

Nuvo Research acquires ZARS Pharma

Nuvo Research acquires ZARS Pharma - MarketLine Financial Deals
Nuvo Research acquires ZARS Pharma
Published May 13, 2011
5 pages — Published May 13, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Nuvo Research, Inc., a Canada-based pharmaceutical company that develops products primarily for the treatment of pain, has acquired ZARS Pharma, Inc., a US-based specialty pharmaceutical company that develops drugs primarily in the area of pain management

  
Source:
Document ID
MA59155_110420
Country
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Nuvo Research acquires ZARS Pharma" May 13, 2011. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Nuvo-Research-acquires-ZARS-Pharma-2052-59615>
  
APA:
MarketLine Financial Deals. (2011). Nuvo Research acquires ZARS Pharma May 13, 2011. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Nuvo-Research-acquires-ZARS-Pharma-2052-59615>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.